Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
Clinical trial NCT00827008 · TERMINATED
Trial details
- NCT number
- NCT00827008
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2011-12-01
- Enrollment
- 821
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.